BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21559835)

  • 1. Matrix metalloproteinase-9 functional promoter polymorphism 1562C>T increased risk of early-onset coronary artery disease.
    Saedi M; Vaisi-Raygani A; Khaghani S; Shariftabrizi A; Rezaie M; Pasalar P; Rahimi Z; Pourmotabbed T
    Mol Biol Rep; 2012 Jan; 39(1):555-62. PubMed ID: 21559835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Polymorphisms, Their Serum Levels, and Activities with Coronary Artery Calcification (CAC) in an Iranian Population.
    Elahirad S; Elieh Ali Komi D; Kiani A; Mohammadi-Noori E; Vaisi-Raygani A; Mozafari H; Bahrehmand F; Saidi M; Toupchi-Khosroshahi V; Salehi N
    Cardiovasc Toxicol; 2022 Feb; 22(2):118-129. PubMed ID: 34731407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Matrix Metalloproteinase-2 (MMP-2) and MMP-9 Promoter Variants, Their Serum Levels, and Activities with Aortic Valve Calcification (AVC) in a Population from Western Iran.
    Heidari Moghadam R; Babajani F; Karami A; Elieh-Ali-Komi D; Hoseini F; Salehi N; Elahirad S; Mohammadi-Noori E; Mohammadi H; Kiani A
    Genet Test Mol Biomarkers; 2024 Jun; 28(6):223-232. PubMed ID: 38708584
    [No Abstract]   [Full Text] [Related]  

  • 4. A functional single nucleotide polymorphism -1562C>T in the matrix metalloproteinase-9 promoter is associated with type 2 diabetes and diabetic foot ulcers.
    Singh K; Agrawal NK; Gupta SK; Singh K
    Int J Low Extrem Wounds; 2013 Sep; 12(3):199-204. PubMed ID: 24043671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A close relationship between functional polymorphism in the promoter region of matrix metalloproteinase-9 and acute myocardial infarction.
    Koh YS; Chang K; Kim PJ; Seung KB; Baek SH; Shin WS; Lim SH; Kim JH; Choi KB
    Int J Cardiol; 2008 Jul; 127(3):430-2. PubMed ID: 17698228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
    Opstad TB; Pettersen AA; Weiss TW; Akra S; Øvstebø R; Arnesen H; Seljeflot I
    Clin Chim Acta; 2012 Jan; 413(1-2):113-20. PubMed ID: 21963461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MMP-9 gene -1562C/T polymorphism in aortic dissection in Chinese hypertensive patients].
    Song WH; Dang AM; Zhu JM; Lü NQ; Liu GZ; Hui RT
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):376-8. PubMed ID: 16780738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Between MMP-2 -1306C>T and MMP-9 -1562C>T Polymorphisms and the Risk and Prognosis of T-Cell Acute Lymphoblastic Leukemia in a Chinese Population: A Case-Control Study.
    Lin CM; Zeng YL; Xiao M; Mei XQ; Shen LY; Guo MX; Lin ZY; Liu QF; Yang T
    Cell Physiol Biochem; 2017; 42(4):1458-1468. PubMed ID: 28719899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between -1562C>T polymorphism in the promoter region of matrix metalloproteinase-9 and coronary artery disease: a meta-analysis.
    Zhang FX; Sun DP; Guan N; Chen JJ; Huo XC; Luo JS
    Genet Test Mol Biomarkers; 2014 Feb; 18(2):98-105. PubMed ID: 24506511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association and Prognostic Significance of the Functional -1562C/T Polymorphism in the Promoter Region of MMP-9 in Turkish Patients with Gastric Cancer.
    Avcı N; Ture M; Deligonul A; Cubukcu E; Olmez OF; Sahinturk S; Topak A; Kurt E; Evrensel T; Şahin AB; Yakut T
    Pathol Oncol Res; 2015 Sep; 21(4):1243-7. PubMed ID: 26156886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-9 1562C>T Gene Polymorphism and Efficacy of Glucocorticoid Therapy in Idiopathic Pulmonary Fibrosis Patients.
    Zhang HT; Fang SC; Wang CY; Wang W; Wu J; Wang C; Xu B; Zhang YM
    Genet Test Mol Biomarkers; 2015 Nov; 19(11):591-7. PubMed ID: 26401883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of IL-1b-3953 C>T and MMP-9-1562C >T Gene Variants on Myocardial Infarction Susceptibility in a Subset of the Iranian Population.
    Daraei A; Mansoori Y; Zendebad Z; Tavakkoly-Bazzaz J; Madadizadeh F; Naghizadeh MM; Arghavani A; Mansoori B
    Genet Test Mol Biomarkers; 2017 Jan; 21(1):33-38. PubMed ID: 27824519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association of matrix metalloproteinase-9 promoter gene polymorphism in obstructive sleep apnea syndrome.
    Yalcınkaya M; Erbek SS; Babakurban ST; Kupeli E; Bozbas S; Terzi YK; Sahin FI
    J Craniomaxillofac Surg; 2015 Sep; 43(7):1099-103. PubMed ID: 26169999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma concentration, genetic variation, and gene expression levels of matrix metalloproteinase 9 in Iranian patients with coronary artery disease.
    Mahmoodi K; Kamali K; Karami E; Soltanpour MS
    J Res Med Sci; 2017; 22():8. PubMed ID: 28400830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of gelatinase B polymorphic variants and its serum levels in atherosclerosis.
    Spurthi KM; Galimudi RK; Srilatha G; Sahu SK; Nallari P; Hanumanth SR
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):850-4. PubMed ID: 22809399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of functional SNP-1562C>T in MMP9 promoter with proliferative diabetic retinopathy in north Indian type 2 diabetes mellitus patients.
    Singh K; Goyal P; Singh M; Deshmukh S; Upadhyay D; Kant S; Agrawal NK; Gupta SK; Singh K
    J Diabetes Complications; 2017 Dec; 31(12):1648-1651. PubMed ID: 28964682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The -1562C/T MMP-9 promoter polymorphism does not predict MMP-9 expression levels or invasive capacity in saphenous vein smooth muscle cells cultured from different patients.
    Maqbool A; Turner NA; Galloway S; Riches K; O'Regan DJ; Porter KE
    Atherosclerosis; 2009 Dec; 207(2):458-65. PubMed ID: 19541314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism c.1562C>T of the MMP-9 is associated with macroangiopathy in type 2 diabetes mellitus.
    Wang Y; Su Y; Xu Y; Pan SH; Liu GD
    Biochem Biophys Res Commun; 2010 Jan; 391(1):113-7. PubMed ID: 19909726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-2 functional promoter polymorphism G1575A is associated with elevated circulatory MMP-2 levels and increased risk of cardiovascular disease in systemic lupus erythematosus patients.
    Bahrehmand F; Vaisi-Raygani A; Kiani A; Rahimi Z; Tavilani H; Navabi SJ; Shakiba E; Hassanzadeh N; Pourmotabbed T
    Lupus; 2012 May; 21(6):616-24. PubMed ID: 22323339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic polymorphisms in matrix metalloproteinase-9 and coronary artery disease in the Chinese Han population: a case-control study.
    Wu HD; Bai X; Chen DM; Cao HY; Qin L
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):707-12. PubMed ID: 23819814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.